Skip to content
DraconiticResearch
Search Sources API
181,713 studies31 sourcesUpdated 32 min ago
Peer-reviewedCC BYCureus

Bilateral Adrenal Masses, Extreme Catecholamine Excess, and Hypercalcitoninemia With Metastatic Neuroendocrine Neoplasia: A Diagnostic Dilemma

  • Ahmed Elhassan1
  • Ahmed Mahgoub2
  • Mohamed Abdel-Hadi Mohamed3
  • Abu-Bekr Mohamed4
  • Isra Ali5
5 affiliations
  1. 1Department of Endocrinology, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, ARE
  2. 2Department of Internal Medicine, Tanta University Hospital, Tanta, EGY
  3. 3Faculty of Medicine, Omdurman Islamic University, Omdurman, SDN
  4. 4Department of Internal Medicine, Detroit Medical Center/Wayne State University School of Medicine, Detroit, USA
  5. 5Department of Biomedical Sciences, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, ARE
Read full textPDFCite

Related

  1. Case Report: Apparent progressive complete mismatch repair protein loss during platinum-based chemotherapy in metastatic rectal neuroendocrine tumour grade 2
    Yue Yang, Gao Li, Jinghui Wang +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  2. The Enemy of My Enemy: Two Cases of De Novo Metastatic Small-Cell Neuroendocrine Prostate Cancer with BRCA2 Alterations and Brain Metastases.
    Mads Fallesen Kjer, Mads Hvid Poulsen, Sanne Kjær-Frifeldt +3
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Metastatic prostate cancer with neuroendocrine differentiation and liver metastases: prognosis and response to platinum-based chemotherapy.
    Christian W Schaaf, G von Amsberg, J J Werner +14
    World journal of urologyPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  4. Bone metastases identify a high-risk subgroup in metastatic neuroendocrine tumors with particular relevance in NETs of unknown primary
    Annie Mathew, Anna Kyewski, Pia Hauptmeier +4
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossref
  5. Efficacy and safety of bevacizumab plus XELOX in patients with unresectable locally advanced or metastatic neuroendocrine tumors
    Huike Wang, Huijing Tan, Yuting Sun +2
    Frontiers in endocrinologyPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{elhassan2026bilateral,
  title = {{Bilateral Adrenal Masses, Extreme Catecholamine Excess, and Hypercalcitoninemia With Metastatic Neuroendocrine Neoplasia: A Diagnostic Dilemma}},
  author = {Ahmed Elhassan and Ahmed Mahgoub and Mohamed Abdel-Hadi Mohamed and Abu-Bekr Mohamed and Isra Ali},
  journal = {Cureus},
  year = {2026},
  month = nov,
  url = {https://europepmc.org/article/PMC/PMC13727991},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Bilateral Adrenal Masses, Extreme Catecholamine Excess, and Hypercalcitoninemia With Metastatic Neuroendocrine Neoplasia: A Diagnostic Dilemma
AU  - Ahmed Elhassan
AU  - Ahmed Mahgoub
AU  - Mohamed Abdel-Hadi Mohamed
AU  - Abu-Bekr Mohamed
AU  - Isra Ali
PY  - 2026
DA  - 2026/11/04
JO  - Cureus
UR  - https://europepmc.org/article/PMC/PMC13727991
SN  - 2168-8184
ER  -